39 participants
Study of Efficacy and Safety of Ligelizumab in Adolescents and Adults With Chronic Inducible Urticaria Who Remain Symptomatic Despite Treatment With H1- Antihistamines
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2024-06-18
- Start Date:
- 2021-11-16
- Completion:
- 2022-08-09
Conditions
- Chronic Inducible Urticaria
Interventions
- DRUG
- OTHER